Knee Arthrosis after ACL Reconstruction: A Long-term Cohort Study with Matched Controls

ACL 重建后的膝关节病:一项具有匹配对照的长期队列研究

基本信息

  • 批准号:
    10159846
  • 负责人:
  • 金额:
    $ 30.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-05-10 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The objectives of this longitudinal outcome study are to evaluate the progression of post-traumatic osteoarthritis (PTOA) following surgical reconstruction of the anterior cruciate ligament (ACL) in male and female patients 15 years after surgery, and to determine if the initial tension applied to the graft at the time of surgery and if sex influences long-term outcomes related to arthrosis. Disruption of the ACL is a common injury that usually requires surgical reconstruction to restore function and prevent PTOA. The “initial graft tension” applied at the time of surgery modulates joint contact mechanics, which in turn, may promote PTOA. However, the effects of low- and high-initial graft tensions on PTOA development are unknown. It is also known that sex is a risk factor for ACL injury and subsequent graft failure. Thus, it is likely that females are at increased risk for PTOA following surgery. The proposed work will leverage a cohort of ACL reconstructed patients that were previously enrolled in a randomized control trial to study the effects of initial graft tension. Patients, who were candidates for ACL reconstruction with an autograft, were randomized into one of two treatment groups: 1) initial graft tension set such that the anterior-posterior (AP) laxity of the reconstructed knee was equal to that of the contralateral normal knee (the “low-tension” treatment; n=46), and 2) initial graft tension set to reduce AP knee laxity by 2 mm relative to that of the contralateral knee (the “high-tension” treatment; n=44). An additional group of subjects without evidence of knee injury (n=60) was recruited to serve as an uninjured control. In the previous funding cycle, we found differences in several outcome measures starting to emerge between the two initial graft tension groups at 7-year follow-up that were not present at 3-year follow-up. In this proposal, the follow-up of this patient cohort and its matched control group will be extended to 15 years, a time point that will enable us to clearly identify those patients who present with both radiographic and symptomatic PTOA. The first hypothesis is that tibiofemoral joint space width of the reconstructed knees of the “high-tension” cohort will be equal to that of the control group, while that of the “low-tension” cohort will be less than that of the control group 15 years after ACL reconstruction. The second hypothesis is that decreases in medial joint space width after ACL reconstruction will be greater in female patients compared to male patients. The comprehensive set of outcomes to be used include imaging modalities to monitor PTOA development and other validated patient- reported, clinical, and functional measures. X-ray measures of joint space width are considered the only validated indicator of PTOA progression for clinical trials of the knee, and will serve as the primary outcome measure for the proposed study. Radiographic assessment of joint health (OARSI score) and a MR-based measure of joint health (WORMS) will serve as secondary imaging outcomes. The Knee Osteoarthritis Outcome Score (KOOS) will be used to identify which patients have symptomatic PTOA. The comprehensive set of outcomes will allow us to establish the long-term effects of initial graft tension, and to systematically evaluate the effects of sex on PTOA development following ACL reconstruction surgery. The proposed study is novel as the ACL reconstructed cohort is comprised of patients with isolated unilateral ACL injuries at the time of injury, includes the long-term follow-up required to assess PTOA development in these patients, and includes a matched control group in order to compare arthrosis development in the uninjured population.
项目摘要/摘要 这项纵向结果研究的目标是评估创伤后的进展 在男性和 手术后15年的女性患者,并确定在 手术和性别影响与关节有关的长期结局。 ACL的破坏是常见的伤害 这通常需要手术重建以恢复功能并防止PTOA。 “初始移植张力” 手术时应用的调节联合接触力学又可能促进PTOA。然而, 低初始移植紧张张力对PTOA发育的影响尚不清楚。还知道性爱 是ACL损伤和随后的移植失败的危险因素。那是女性的风险增加 手术后的PTOA。拟议的工作将利用一组ACL重建患者的队列 先前参加了一项随机对照试验,以研究初始移植张力的影响。患者,谁 用自体移植进行ACL重建的候选者被随机分为两个治疗组之一:1) 初始移植张力集,使重建的膝盖的前后骨(AP)松弛等于 对侧正常膝盖(“低张力”治疗; n = 46)和2)最初的移植张力设置以减少AP 相对于对侧膝盖的膝盖松弛2毫米(“高张紧”治疗; n = 44)。另一个 招募了没有膝盖损伤证据的受试者组(n = 60),以作为未受伤的对照。在 以前的资金周期,我们发现两者之间出现的几种结果指标的差异 在3年随访中不存在的7年随访中的初始移植张力组。在此提案中, 该患者队列及其匹配的对照组的后续措施将延长至15年,这个时间点将 使我们能够清楚地识别出具有射线照相和有症状PTOA的患者。这 第一个假设是“高张力”队列重建膝盖的胫骨关节空间宽度将 等于对照组的,而“低张紧”队列的组将小于对照组 ACL重建15年后的组。第二个假设是中位关节空间宽度下降 与男性患者相比,在ACL重建后,女性患者将更大。综合套装 要使用的结果包括成像模式以监测PTOA开发和其他经过验证的患者 - 报告,临床和功能测量。 X射线尺寸的关节宽度被认为是唯一的 经过验证的PTOA进展指标用于膝盖的临床试验,并将作为主要结果 拟议研究的量度。关节健康评估(OARSI评分)和MR基于MR 关节健康(蠕虫)的度量将作为次要成像结果。膝盖骨关节炎 结果评分(KOO)将用于确定哪些患者有症状PTOA。综合 一组结果将使我们能够建立初始移植张力的长期影响,并系统地建立 评估ACL重建手术后性别对PTOA发育的影响。拟议的研究是 小说,因为ACL重建的队列由当时孤立的单侧ACL损伤患者组成 伤害包括评估这些患者PTOA开发所需的长期随访,以及 包括一个匹配的对照组,以比较未受伤的人群中的关节炎发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Braden C Fleming的其他基金

Knee Arthrosis after ACL Reconstruction: A Long-term Cohort Study with Matched Controls
ACL 重建后的膝关节炎:具有匹配对照的长期队列研究
  • 批准号:
    10424422
    10424422
  • 财政年份:
    2019
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Planning A Clinical Trial of Bio-enhanced ACL Repair versus ACL Reconstruction
计划生物增强 ACL 修复与 ACL 重建的临床试验
  • 批准号:
    9233601
    9233601
  • 财政年份:
    2017
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Non-invasive assessment of ligament healing in vivo
体内韧带愈合的无创评估
  • 批准号:
    8928046
    8928046
  • 财政年份:
    2014
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Non-invasive assessment of ligament healing in vivo
体内韧带愈合的无创评估
  • 批准号:
    8759439
    8759439
  • 财政年份:
    2014
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Non-invasive assessment of ligament healing in vivo
体内韧带愈合的无创评估
  • 批准号:
    9136641
    9136641
  • 财政年份:
    2014
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
RI COBRE: BIOENGINEERING CORE
RI COBRE:生物工程核心
  • 批准号:
    8360473
    8360473
  • 财政年份:
    2011
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
RI COBRE: BIOENGINEERING CORE
RI COBRE:生物工程核心
  • 批准号:
    8168033
    8168033
  • 财政年份:
    2010
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Biologically Enhanced Healing of Autograft ACL Reconstruction.
自体移植 ACL 重建的生物增强愈合。
  • 批准号:
    8020913
    8020913
  • 财政年份:
    2009
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Biologically Enhanced Healing of Autograft ACL Reconstruction.
自体移植 ACL 重建的生物增强愈合。
  • 批准号:
    8213690
    8213690
  • 财政年份:
    2009
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
RI COBRE: BIOENGINEERING CORE
RI COBRE:生物工程核心
  • 批准号:
    7959901
    7959901
  • 财政年份:
    2009
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:

相似国自然基金

纳米纤维/多孔材料复合构筑骨-韧带-骨一体化支架用于前交叉韧带重建研究
  • 批准号:
    32301145
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多尺度分级结构电活性人工韧带的构建及其促前交叉韧带有序重构研究
  • 批准号:
    32371402
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
SNP rs970547通过降低COL12A1蛋白稳定性启动内质网应激诱发前交叉韧带损伤易感的机制研究
  • 批准号:
    82360418
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
肌腱-骨组织转变促进前交叉韧带重建连接处再生的功能与机制研究
  • 批准号:
    32301135
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
使用生物3D打印方法仿生构建具有韧带止点分层结构的人工韧带,重建前交叉韧带止点生理结构
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

CollaLink: Guided-regenerative Scaffold for Augmentation of Anterior Cruciate Ligament Repair
CollaLink:用于增强前十字韧带修复的引导再生支架
  • 批准号:
    10760639
    10760639
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Graft harvest as a model of tendon injury; Trajectory of recovery and clinical outcomes
移植物收获作为肌腱损伤的模型;
  • 批准号:
    10672279
    10672279
  • 财政年份:
    2022
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Intraoperative Kit for AuNP-Tissue Grafts
AuNP 组织移植术中套件
  • 批准号:
    10598225
    10598225
  • 财政年份:
    2022
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Graft harvest as a model of tendon injury; Trajectory of recovery and clinical outcomes
移植物收获作为肌腱损伤的模型;
  • 批准号:
    10417618
    10417618
  • 财政年份:
    2022
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别:
Intraoperative Kit for AuNP-Tissue Grafts
AuNP 组织移植术中套件
  • 批准号:
    10773571
    10773571
  • 财政年份:
    2022
  • 资助金额:
    $ 30.92万
    $ 30.92万
  • 项目类别: